| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | AS601245 | GDSC1000 | pan-cancer | AAC | -0.0013 | 1 |
| mRNA | masitinib | CTRPv2 | pan-cancer | AAC | 0.0013 | 1 |
| mRNA | Bortezomib | gCSI | pan-cancer | AAC | 0.002 | 1 |
| mRNA | tosedostat | CTRPv2 | pan-cancer | AAC | 0.0012 | 1 |
| mRNA | BRD-K27188169 | CTRPv2 | pan-cancer | AAC | -0.0017 | 1 |
| mRNA | neratinib | CTRPv2 | pan-cancer | AAC | -0.001 | 1 |
| mRNA | PF-3758309 | CTRPv2 | pan-cancer | AAC | -0.0012 | 1 |
| mRNA | Ko-143 | CTRPv2 | pan-cancer | AAC | 0.00093 | 1 |
| mRNA | pac-1 | GDSC1000 | pan-cancer | AAC | -0.00079 | 1 |
| mRNA | leptomycin B | CTRPv2 | pan-cancer | AAC | -0.00074 | 1 |